https://endpts.com/merck-scraps-their-425m-covid-19-drug-in-latest-pandemic-setback/

After a $425 Million dollar set-back Merck is reloading with another prospect therapeutic with Phase II / III trials as we speak.  

I wonder if Merck has even heard of us, or more importantly, from us.